Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1260P (RNA, U6 small nuclear 1260, pseudogene) is a pseudogene of the U6 small nuclear RNA (snRNA) gene family in humans[1][4]. As a pseudogene, it is a nonfunctional genetic element derived from the U6 snRNA gene, which itself is an essential component of the spliceosome complex involved in the removal of introns from pre-mRNA during RNA splicing in eukaryotes[5][3]. Pseudogenes like RNU6-1260P typically arise from retrotransposition or gene duplication events but do not produce functional RNA or protein products[2]. There is no evidence to suggest that RNU6-1260P has a direct biological function or disease association, nor is it considered a therapeutic target. Its primary scientific relevance is as a genomic marker of the evolutionary history and retrotranspositional dynamics of non-coding RNA genes[2][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1260, pseudogene (RNU6-1260P).